glutathione and liver in the Treatment of Fatty Liver/NASH/NAFLD Dysregulation of glutathione synthesis in

Lpez-Carrillo, L

Priority Applications (1) Applications Claiming Priority (4) Related Parent Applications (1) Publications (2) Family ID=46969763 Family Applications (3) Family Applications Before (1) Family Applications After (1) Country Status (8) Cited By (1) Families Citing this family (14) Citations (5) Family Cites Families (1) 2012 2012-04-02 AU AU2012240424A patent/AU2012240424B2/en active Active 2012-04-02 US US14/009,459 patent/US9150613B2/en active Active 2012-04-02 CA CA2832113A patent/CA2832113C/en active Active 2012-04-02 CN CN201280026925.2A patent/CN103582490B/en active Active 2012-04-02 WO PCT/US2012/031815 patent/WO2012138599A2/en not_active Ceased 2012-04-02 JP JP2014503898A patent/JP6173298B2/en active Active 2012-04-02 EP EP12768043.7A patent/EP2709650B1/en active Active 2012-04-02 ES ES12768043.7T patent/ES2622385T3/en active Active 2013 2013-02-15 US US13/768,497 patent/US8598118B2/en active Active 2015 2015-08-07 US US14/821,184 patent/US20170049843A1/en not_active Abandoned

OPTOVITE B12 1000 micrograms Injectable Solution requires a prescription in Spain

J.VaziriN

When ingested, these chains of amino acids can be broken down and used for energy